@partylamb66
Active 1 week, 3 days ago-
Velling Horton posted an update 1 week, 4 days ago
In recent decades, marine microorganisms have become known for their ability to produce a wide variety of secondary bioactive metabolites. Several compounds have been isolated from marine microorganisms for the development of novel bioactives for the food and pharmaceutical industries. In this study, a number of microalgae were evaluated for their…[Read more]
-
Velling Horton posted an update 1 week, 5 days ago
s then 0.01), and Lewy bodies (4.76, 2.07-10.95, P less then 0.01). Increased amyloid phase associated with CAA (2.27, 1.07-4.80, P = 0.03) and Lewy bodies (6.09, 1.66-22.33, P = 0.01). In summary, we describe widespread distributions of CAA, LATE-NC and Lewy bodies that progressively accumulate alongside plaques and tangles in Alzheimer’s d…[Read more]
-
Velling Horton posted an update 1 week, 6 days ago
To evaluate a novel aqueous-based liquid embolic (Embrace Hydrogel Embolic System, [HES]) that has been developed to embolize hypervascular tumors by filling the tumor vascular bed and solidifying into a hydrogel. HES was evaluated for embolization safety and efficacy relative to microspheres in a preclinical rabbit kidney model.
A renal…[Read more]
-
Velling Horton posted an update 2 weeks, 6 days ago
No difference in cerebral oxygenation in premature infants transitioning from nCPAP to HFNC was observed. This finding is reassuring and further supports the use of HFNC in preterm infants.The treatment of moderate to severe plaque psoriasis in patients with history of malignancy is challenging. To review the studies reporting the experience with…[Read more]
-
Velling Horton became a registered member 2 weeks, 6 days ago